Home / Innere Medizin / Onkologie / ESMO is doing a lot for young oncologists
Dr. Claudia Cardone

ESMO is doing a lot for young oncologists

Dr. Claudia Cardone, Università Vanvitelli in Naples, Italy, is currently a research fellow at the Medical University of Vienna to investigate biomarkers in CRC. She also describes what ESMO young oncologists can do for «youngsters».

Cookies aktivieren

Um das Video anzusehen, müssen Sie Statistikcookies akzeptieren.

Einstellungen verwalten
Source: ESMO 2018 Congress

Cardone C et al., AXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT) + cetuximab in RAS wild type (WT) patients (pts). Abstract #96P

Cremolini C et al., TRIBE2: a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts). Abstract #LBA2

LOGIN